The DOI matches its Crossref record; 281 of the 281 references it cites were found in a registry or an index.
Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
Abstract
The past few decades have witnessed an evolution of nanomedicine from biologically inert entities to more smart systems, aimed at advancing in vivo functionality. However, we should recognize that most systems still rely on reasonable explanation—including some over-explanation—rather than definitive evidence, which is a watershed radically determining the speed and extent of advancing nanomedicine. Probing nano–bio interactions and desirable functionality at the tissue, cellular, and molecular levels is most frequently overlooked. Progress toward answering these questions will provide instructive insight guiding more effective chemo-physical strategies. Thus, in the next generation, we argue that much effort should be made to provide definitive evidence for proof-of- mechanism, in lieu of creating many new and complicated systems for similar proof-of- concept .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–281 of 281
Clark, A. J., Wiley, D. T., Zuckerman, J. E., Webster, P., Chao, J., Lin, J., Yen, Y., & Davis, M. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603018113 · Cited by 168
Facile Generation of Tumor‐pH‐Labile Linkage‐Bridged Block Copolymers for Chemotherapeutic Delivery
Sun, C., Liu, Y., Du, J., Cao, Z., Xu, C., & Wang, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509507 · Cited by 165
Xie, R., Dong, L., Du, Y., Zhu, Y., Hua, R., Zhang, C., & Chen, X. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516524113 · Cited by 165
Sheikov, N., McDannold, N., Jolesz, F., Zhang, Y.-Z., Tam, K., & Hynynen, K. (2006) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2006.05.015 · Cited by 163
Seynhaeve, A. L. B., Dicheva, B. M., Hoving, S., Koning, G. A., & ten Hagen, T. L. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.034 · Cited by 157
Liu, G., Zhang, G., Hu, J., Wang, X., Zhu, M., & Liu, S. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05060 · Cited by 157
Overcoming key biological barriers to cancer drug delivery and efficacy
Kim, S. M., Faix, P. H., & Schnitzer, J. E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.016 · Cited by 157
Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles
Jiang, W., Huang, Y., An, Y., & Kim, B. Y. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b02028 · Cited by 154
Hickey, J. W., Vicente, F. P., Howard, G. P., Mao, H., & Schneck, J. P. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03734 · Cited by 152
Role of tumor vascular architecture in drug delivery
Narang, A. S., & Varia, S. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.04.002 · Cited by 149
Uchida, H., Itaka, K., Nomoto, T., Ishii, T., Suma, T., Ikegami, M., Miyata, K., Oba, M., Nishiyama, N., & Kataoka, K. (2014) · Journal of the American Chemical Society · doi:10.1021/ja506194z · Cited by 149
Self-citationTumor target amplification: Implications for nano drug delivery systems
Seidi, K., Neubauer, H. A., Moriggl, R., Jahanban-Esfahlan, R., & Javaheri, T. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.020 · Cited by 145
Li, J., Ke, W., Wang, L., Huang, M., Yin, W., Zhang, P., Chen, Q., & Ge, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.029 · Cited by 144
Self-citationVascular permeability changes involved in tumor metastasis
García-Román, J., & Zentella‐Dehesa, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.005 · Cited by 142
Li, J., Anraku, Y., & Kataoka, K. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004180 · Cited by 142
Self-citationFocus on Fundamentals: Achieving Effective Nanoparticle Targeting
Tietjen, G. T., Bracaglia, L. G., Saltzman, W. M., & Pober, J. S. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.05.003 · Cited by 140
Quader, S., Liu, X., Chen, Y., Mi, P., Chida, T., Ishii, T., Miura, Y., Nishiyama, N., Cabral, H., & Kataoka, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.033 · Cited by 139
Self-citationMartin, J. D., Panagi, M., Wang, C., Khan, T., Martin, M. R., Voutouri, C., Toh, K., Papageorgis, P., Mpekris, F., Polydorou, C., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07865 · Cited by 139
Self-citationIntegrin-mediated targeting of drug delivery to irradiated tumor blood vessels
Hallahan, D. E., Geng, L., Qu, S., Scarfone, C., Giorgio, T. D., Donnelly, E. F., Gao, X., & Clanton, J. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00238-6 · Cited by 134
Ge, Z., Chen, Q., Osada, K., Liu, X., Tockary, T. A., Uchida, S., Dirisala, A., Ishii, T., Nomoto, T., Toh, K., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.086 · Cited by 131
Self-citationTranscytosis of Nanomedicine for Tumor Penetration
Liu, Y., Huo, Y., Yao, L., Xu, Y., Meng, F., Li, H., Sun, K., Zhou, G., Kohane, D. S., & Tao, K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03211 · Cited by 129
Gonzalez-Carter, D., Liu, X., Tockary, T. A., Dirisala, A., Toh, K., Anraku, Y., & Kataoka, K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002016117 · Cited by 127
Self-citationOe, Y., Christie, R. J., Naito, M., Low, S. A., Fukushima, S., Toh, K., Miura, Y., Matsumoto, Y., Nishiyama, N., Miyata, K., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.041 · Cited by 126
Self-citationLi, J., Wei, K., Zuo, S., Xu, Y., Zha, Z., Ke, W., Chen, H., & Ge, Z. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201702108 · Cited by 126
Self-citationItaka, K., Kanayama, N., Nishiyama, N., Jang, W., Yamasaki, Y., Nakamura, K., Kawaguchi, H., & Kataoka, K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047174r · Cited by 125
Self-citationPolyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery system
Takemoto, H., Ishii, A., Miyata, K., Nakanishi, M., Oba, M., Ishii, T., Yamasaki, Y., Nishiyama, N., & Kataoka, K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.015 · Cited by 123
Self-citationYoo, D., Magsam, A. W., Kelly, A. M., Stayton, P. S., Kievit, F. M., & Convertine, A. J. (2017) · ACS Nano · doi:10.1021/acsnano.7b03426 · Cited by 121
Heterogeneity of tumor endothelial cells and drug delivery
Hida, K., Maishi, N., Sakurai, Y., Hida, Y., & Harashima, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.008 · Cited by 120
Guided delivery of polymer therapeutics using plasmonic photothermal therapy
Gormley, A. J., Larson, N., Sadekar, S., Robinson, R., Ray, A., & Ghandehari, H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.04.002 · Cited by 119
Takemoto, H., Miyata, K., Hattori, S., Ishii, T., Suma, T., Uchida, S., Nishiyama, N., & Kataoka, K. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201300178 · Cited by 119
Self-citationXie, J., Gonzalez‐Carter, D., Tockary, T. A., Nakamura, N., Xue, Y., Nakakido, M., Akiba, H., Dirisala, A., Liu, X., Toh, K., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b09991 · Cited by 119
Self-citationAnraku, Y., Kishimura, A., Kobayashi, A., Oba, M., & Kataoka, K. (2011) · Chemical Communications · doi:10.1039/c1cc11465d · Cited by 117
Self-citationTodd, N., Angolano, C., Ferran, C. J., Devor, A., Borsook, D., & McDannold, N. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.040 · Cited by 116
Targeting specific cells in the brain with nanomedicines for CNS therapies
Zhang, F., Lin, Y.-A., Kannan, S., & Kannan, R. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.013 · Cited by 114
MacEwan, S. R., & Chilkoti, A. (2012) · Nano Letters · doi:10.1021/nl301529p · Cited by 111
Al-Ahmady, Z. S., Jasim, D. A., Ahmad, S. S., Wong, R., Haley, M., Coutts, G., Schießl, I., Allan, S. M., & Kostarelos, K. (2019) · ACS Nano · doi:10.1021/acsnano.9b01808 · Cited by 111
Wen, J., Wu, D., Qin, M., Liu, C., Wang, L., Xu, D., Vinters, H. V., Liu, Y., Kranz, E., Guan, X., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0434-z · Cited by 108
DePEGylation strategies to increase cancer nanomedicine efficacy
Kong, L., Campbell, F., & Kros, A. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00417j · Cited by 107
Overcoming Nanoparticle-Mediated Complement Activation by Surface PEG Pairing
Pannuzzo, M., Esposito, S. A., Wu, L., Key, J., Aryal, S., Celia, C., Marzio, L. D., Moghimi, S. M., & Decuzzi, P. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01011 · Cited by 107
Suma, T., Miyata, K., Anraku, Y., Watanabe, S. T., Christie, R. J., Takemoto, H., Shioyama, M., Gouda, N. A., Ishii, T., Nishiyama, N., et al. (2012) · ACS Nano · doi:10.1021/nn301164a · Cited by 104
Self-citationYen, H., Cabral, H., Mi, P., Toh, K., Matsumoto, Y., Liu, X., Koori, H., Kim, A., Miyazaki, K., Miura, Y., et al. (2014) · ACS Nano · doi:10.1021/nn504836s · Cited by 104
Self-citationJardim, D. L. F., Groves, E. S., Breitfeld, P. P., & Kurzrock, R. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.10.009 · Cited by 104
Suzuki, K., Miura, Y., Mochida, Y., Miyazaki, T., Toh, K., Anraku, Y., Melo, V. A., Liu, X., Ishii, T., Nagano, O., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.021 · Cited by 98
Self-citationShi, P., Wang, X., Davis, B., Coyne, J., Dong, C., Reynolds, J., & Wang, Y. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202004206 · Cited by 97
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy
Detappe, A., Kunjachan, S., Sancey, L., Motto‐Ros, V., Biancur, D. E., Drané, P., Guièze, R., Makrigiorgos, G. M., Tillement, O., Langer, R., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.021 · Cited by 96
Christie, R. J., Miyata, K., Matsumoto, Y., Nomoto, T., Menasco, D., Lai, T. C., Pennisi, M., Osada, K., Fukushima, S., Nishiyama, N., et al. (2011) · Biomacromolecules · doi:10.1021/bm2006714 · Cited by 94
Self-citationLiving Unimodal Growth of Polyion Complex Vesicles via Two-Dimensional Supramolecular Polymerization
Anraku, Y., Kishimura, A., Yamasaki, Y., & Kataoka, K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3096587 · Cited by 93
Self-citationYoshinaga, N., Ishii, T., Naito, M., Endo, T., Uchida, S., Cabral, H., Osada, K., & Kataoka, K. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08816 · Cited by 91
Self-citationKim, H. J., Ogura, S., Otabe, T., Kamegawa, R., Sato, M., Kataoka, K., & Miyata, K. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00843 · Cited by 90
Self-citationInfluence of RNA Strand Rigidity on Polyion Complex Formation with Block Catiomers
Hayashi, K., Chaya, H., Fukushima, S., Watanabe, S. T., Takemoto, H., Osada, K., Nishiyama, N., Miyata, K., & Kataoka, K. (2016) · Macromolecular Rapid Communications · doi:10.1002/marc.201500661 · Cited by 85
Self-citationLundy, D. J., Lee, K., Peng, I.-C., Hsu, C., Lin, J.-H., Chen, K., Tien, Y., & Hsieh, P. C. H. (2018) · ACS Nano · doi:10.1021/acsnano.8b03785 · Cited by 85
In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers
Watanabe, S. T., Hayashi, K., Toh, K., Kim, H. J., Liu, X., Chaya, H., Fukushima, S., Katsushima, K., Kondo, Y., Uchida, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09856-w · Cited by 84
Self-citationDirisala, A., Uchida, S., Toh, K., Li, J., Osawa, S., Tockary, T. A., Liu, X., Abbasi, S., Hayashi, K., Mochida, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb8133 · Cited by 81
Self-citationDirisala, A., Uchida, S., Tockary, T. A., Yoshinaga, N., Li, J., Osawa, S., Gorantla, L., Fukushima, S., Osada, K., & Kataoka, K. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1550646 · Cited by 77
Self-citationKinoh, H., Miura, Y., Chida, T., Liu, X., Mizuno, K., Fukushima, S., Morodomi, Y., Nishiyama, N., Cabral, H., & Kataoka, K. (2016) · ACS Nano · doi:10.1021/acsnano.6b00900 · Cited by 72
Self-citationKinoh, H., Quader, S., Shibasaki, H., Liu, X., Maity, A. R., Yamasoba, T., Cabral, H., & Kataoka, K. (2020) · ACS Nano · doi:10.1021/acsnano.0c03386 · Cited by 70
Self-citationLi, J., Chen, Q., Zha, Z., Li, H., Toh, K., Dirisala, A., Matsumoto, Y., Osada, K., Kataoka, K., & Ge, Z. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.024 · Cited by 69
Self-citationPolyvalent Display of Biomolecules on Live Cells
Shi, P., Zhao, N., Lai, J., Coyne, J., Gaddes, E. R., & Wang, Y. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712596 · Cited by 68
Li, J., Han, Y., Chen, Q., Shi, H., Rehman, S. U., Siddiq, M., Ge, Z., & Liu, S. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21383h · Cited by 67
Self-citationJyotsana, N., Zhang, Z., Himmel, L. E., Yu, F. Z., & King, M. R. (2019) · Science Advances · doi:10.1126/sciadv.aaw4197 · Cited by 67
Osawa, S., Osada, K., Hiki, S., Dirisala, A., Ishii, T., & Kataoka, K. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01456 · Cited by 66
Self-citationChida, T., Miura, Y., Cabral, H., Nomoto, T., Kataoka, K., & Nishiyama, N. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.035 · Cited by 65
Self-citationTargeting drug delivery to radiation-induced neoantigens in tumor microvasculature
Hallahan, D. E., Geng, L., Cmelak, A. J., Chakravarthy, A. B., Martin, W., Scarfone, C., & González, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00335-2 · Cited by 61
Wadkins, R. M., Morton, C. L., Weeks, J. K., Oliver, L., Wierdl, M., Danks, M. K., & Potter, P. M. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.2.355 · Cited by 61
Radiation-induced tumor neoantigens: imaging and therapeutic implications.
Corso, C. D., Ali, A. N., & Díaz, R. (2011) · Europe PMC (PubMed Central) · Cited by 59
Li, J., Ke, W., Li, H., Zha, Z., Han, Y., & Ge, Z. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500379 · Cited by 59
Self-citationHenrich‐Noack, P., Nikitovic, D., Neagu, M. T., Docea, A. O., Engin, A. B., Gelperina, S. E., Штильман, М. И., Mitsias, P. D., Tzanakakis, G. N., Gozes, I., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.016 · Cited by 59
Polyamine‐Mediated Stoichiometric Assembly of Ribonucleoproteins for Enhanced mRNA Delivery
Li, J., He, Y., Wang, W., Wu, C., Hong, C., & Hammond, P. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707466 · Cited by 55
Self-citationSurnar, B., Basu, U., Banik, B., Ahmad, A., Marples, B., Kolishetti, N., & Dhar, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816429115 · Cited by 54
Li, J., Xiao, S., Xu, Y., Zuo, S., Zha, Z., Ke, W., He, C., & Ge, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02808 · Cited by 53
Self-citationHorise, Y., Maeda, M., Konishi, Y., Okamoto, J., Ikuta, S., Okamoto, Y., Ishii, H., Yoshizawa, S., Umemura, S., Ueyama, T., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00545 · Cited by 52
Self-citationTockary, T. A., Foo, W., Dirisala, A., Chen, Q., Uchida, S., Osawa, S., Mochida, Y., Liu, X., Kinoh, H., Cabral, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b04676 · Cited by 42
Self-citationNanomedicine and cancer immunotherapy – targeting immunosuppressive cells
Andón, F. T., & Alonso, M. J. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1073295 · Cited by 39
Enhanced target recognition of nanoparticles by cocktail PEGylation with chains of varying lengths
Ishii, T., Miyata, K., Anraku, Y., Naito, M., Yi, Y., Jinbo, T., Takae, S., Fukusato, Y., Hori, M., Osada, K., et al. (2015) · Chemical Communications · doi:10.1039/c5cc06661a · Cited by 38
Self-citationFunctional T cell activation by smart nanosystems for effective cancer immunotherapy
Yang, W., Zhou, Z., Lau, J., Hu, S., & Chen, X. S. (2019) · Nano Today · doi:10.1016/j.nantod.2019.05.004 · Cited by 37
Delivery Systems as Vital Tools in Drug Repurposing
Czech, T., Lalani, R., & Oyewumi, M. O. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1333-z · Cited by 35
Khan, T., Igarashi, K., Tanabe, A., Miyazawa, T., Fukushima, S., Miura, Y., Matsumoto, Y., Yamasoba, T., Matsumoto, A., Cabral, H., et al. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00530 · Cited by 34
Self-citationDrug-induced amplification of nanoparticle targeting to tumors
Lin, K., Kwon, E. J., Lo, J. H.-J., & Bhatia, S. N. (2014) · Nano Today · doi:10.1016/j.nantod.2014.09.001 · Cited by 30
Stackhouse, M. A., Buchsbaum, D. J., Kancharla, S. R., et al. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700049 · Cited by 28
Targeting central nervous system pathologies with nanomedicines
Mizrahy, S., Gutkin, A., Decuzzi, P., & Peer, D. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1533556 · Cited by 22
Involvement of Caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomes
Sakurai, Y., Kato, A., & Harashima, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.086 · Cited by 12
Cited by
Hersh, A. M., Alomari, S., & Tyler, B. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084153 · Cited by 478
A translational framework to DELIVER nanomedicines to the clinic
Joyce, P., Allen, C. J., Alonso, M. J., Ashford, M., Bradbury, M. S., Germain, M., Kavallaris, M., Langer, R., Lammers, T., Peracchia, M. T., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01754-7 · Cited by 333
Controlling the biodistribution and clearance of nanomedicines
Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303
Self-citationLiposomes in Cancer Therapy: How Did We Start and Where Are We Now
Fulton, M. D., & Najahi-Missaoui, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076615 · Cited by 258
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Metadata
- Authors
- Li, J., & Kataoka, K.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-12-28
- Volume
- 143
- Issue
- 2
- Pages
- 538-559
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W3114576313
- Cited by
- 281
- References
- 281
- FWCI
- 7.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.